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Drug-induced liver injury encompasses a spectrum of diseases ranging from mild
biochemical abnormalities to acute liver failure; example of this scenery is hepatotoxicity
caused by the ﬁrst-line antituberculous drugs isoniazid, rifampin and pyrazinamide,
which are basic for treatment of drug-sensible and drug-resistant tuberculosis. In the
search for pharmacological alternatives to prevent liver damage, antitubercular drugs have
been the subject of numerous studies and published reviews, a great majority of them
carried out by Asian countries. At the same time, hepatoprotectors from plant source are
now emerging as a possible alternative to counteract the toxic effects of these therapeutic
agents. The present review aims to highlight the most recent studies on the subject, based
information published in scientiﬁc databases such as Scopus and PubMed.1. Introduction
Tuberculosis (TB) is a disease that affects one third of the
world's population; in 2014, nearly 9.6 million cases were re-
ported and close to 2 million deaths [1–3]. At present, there is an
alarming increase of multidrug-resistant-TB (MDR-TB) and of
extended drug-resistant-TB (XDR-TB) cases; the former are
resistant to RIF, PZA and INH (basic drugs) and XDR cases are
resistant to RIF, INH, ﬂuoroquinolones and to a second-line
injectable drug (amikacin, capreomycin or kanamycin). The
World Health Organization (WHO) TB Report 2012 indicates
that 4% of new cases and 20% of retreated cases are MDR and
that <20% receive adequate treatment [2,4]. On the other hand,
around 60% of the patients with MDR-TB are cured and 10%
become XDR-TB; of the latter, only 10% are cured [2–5].RIF, INH and PZA are basic for treating sensitive or mono-
resistant TB, and these mainly cause liver damage, as well as
neuropathy, hypersensitivity, nephrotoxicity, nausea, vomiting
and gastritis. The hepatotoxicity incidence depends on the
population studied, treatment time and factors such as age,
malnutrition, alcoholism, diabetes mellitus, arthritis, HIV/AIDS,
host genetic, exposure to other drugs, etc [2,4,6–8]. For the
treatment of sensitive TB, a multi-therapy is used, based on
four ﬁrst-line drugs (RIF, INH, PZA, EMB or STR) for 2
months and a mixture of RIF/INH for 8 months. For latent TB,
RIF/INH is administered for 3 months or RIF/PZA for 4 months;
this treatment causes 2.5%–13% of liver damage, respectively.
When the INH is administered alone for 9 months, the hepato-
toxicity increases to 1.6% and it increases to 2.6% when RIF/
INH mixture is used [8–10].
MDR-TB is treated with up to eight drugs, including ﬁrst and
second line (amikacin, capreomycin, ﬂuoroquinolones, cyclo-
serine, ethionamide, etc), for a period of 8–30 months; in this
case, the treatment causes severe liver damage in >69% of pa-
tients. Subsequently, secondary effects provoke non-adherence
to treatment and contribute to treatment failure, propitiating
the appearance of drug resistance (DR) [8,9]. It is noteworthy that
for contacts of MDR-TB cases, the PZA/EMB combination or
ﬂuoroquinolones are employed for treatment [4,11,12].cess article under the CC BY-NC-ND license (http://
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liver; this organ is the most affected when the substance is
metabolized and generates more toxic products, such as free
radicals (FR). This alters the structural integrity and function-
ality of the liver, generates inﬂammation, steatosis, induces
hepatitis, liver ﬁbrosis, nonalcoholic cirrhosis, necrosis and even
hepatocellular carcinoma, and these are among the causes of
drug withdrawal from the market [13–16].
The majority of epidemiological studies on hepatotoxicity
have been conducted in Europe, Asia and the U.S., and inci-
dence varies among the different regions of the world. The
proportion is higher in developing countries as compared with
developed countries; for example, it has been reported that in
India there is a higher incidence of adverse effects, the mixture
of RIF/INH/PZA causing up to 30% of hepatotoxicity, while in
other countries this percentage is 23% [17,18]. This type of study
has also been carried out in Sub-Saharan Africa, but the inci-
dence of hepatotoxicity has not been reported [8,12].
Since the discovery of INH (1952), the incidence of hepa-
totoxicity is present in 2% of patients and 20% of these show an
increase in the values of hepatic enzymes, such as glutamic
oxaloacetic transaminase (GOT) or aspartate aminotransferase
(AST) and glutamic pyruvic transferase (GPT) or alanine
aminotransferase (ALT) and alkaline phosphatase (ALP) [19].
With the introduction of RIF (in 1963), cases of hepatitis were
more frequent, but the increase was greater when the mixture
INH/RIF was employed for TB treatment [11]. In the decade of
the 1950s, PZA was introduced, being the most active drug
against MDR Mycobacterium tuberculosis strains, but it is
more hepatotoxic, and cases of hepatotoxicity increased when
the mixture of INH/RIF/PZA was used, reaching values of up
to 60% [8,11,12,20].
The pathogenesis of the hepatotoxicity caused by the INH/
RIF mixture is not yet very clear. It generates very reactive
compounds such as FR, these favoring the development of
oxidative stress (OS), lipid peroxidation and choline deﬁciency.
Phospholipoprotein synthesis and integrity of the cellular
membrane of the hepatocytes are altered. Moreover, the levels of
glutathione present in them are reduced [11,12,20].
Although the mechanism by which anti-TB drugs induce
hepatotoxicity is not yet fully elucidated, it is known that INH
and RIF are metabolized by diverse hepatic enzymes of the P450
cytochrome family [12]. RIF is an inducer of CYP2D6 and
CYP3A4 isoforms of the cytochrome while INH induces
CYP2E1 [20–22]. These generate toxic metabolites, such as
hydrazine (toxic metabolite of INH), giving rise to OS in
humans as well as in animals, and also generate hepatic
necrosis. Likewise, INH inhibits cytochrome P450 1A2
reductase, which is involved in the detoxiﬁcation of its
metabolite (hydrazine); therefore, the hepatotoxicity of this
drug increases [12,17,23]. Moreover, it has been asserted that
RIF increases the biotransformation of INH by stimulating the
liver's enzymatic system; in turn, affecting the toxic metabolites
of the INH and increasing OS. Furthermore, PZA, once
metabolized, becomes pyrazinoic acid (PA), which causes
granulomatous hepatitis [12]. In addition, there is strong
evidence that host genetic factors inﬂuence individual
susceptibility to develop hepatotoxicity by anti-TB, such as
polymorphisms in NAT2, CYP2E1 and GST genes, this is a topic
that is getting much attention. Similarly, the effects of GST
polymorphisms on genetic susceptibility to anti-TB damage have
been reported, particularly for GSTM1 and GSTT1 genes [24].Due to the fact that the three main anti-TB drugs (RIF, INH,
and PZA) are those that cause the greatest liver damage and
cannot be substituted today, research is being conducted aimed
at preventing or reducing the adverse side effects by using herbal
extracts and/or natural compounds isolated from these, with a
hepatoprotective effect. Among natural products, we can
mention silymarin, resveratrol, vitamins E and C, polyphenols
and garlic, among others, which do not interfere with the anti-
TB effect of the drugs. It is noteworthy that the inhibition of
cytochrome P450 in its isoform CYP2E1, together with the
antioxidant effect of these substances, is beneﬁcial and is the
most common mechanism of herbal remedies and isolated nat-
ural compounds. Therefore, they are the most frequently rec-
ommended substances for protection from the hepatotoxicity
induced by anti-TB drugs [17,21,25–27].
In the present paper, an exhaustive search was carried out on
the hepatoprotective effect of extracts and/or compounds ob-
tained from medicinal plants against liver damage induced by
anti-TB drugs (RIF/INH or RIF/INH/PZA mixture) in preclini-
cal models, in vivo and in vitro. The main scientiﬁc sources
consulted were the Scopus and PubMed databases. In this
manuscript we describe 101 references published from the year
2000 to date. The key words employed included medicinal
plants, hepatoprotective effect, antitubercular drugs-induced
hepatotoxicity and natural compounds.
It is noteworthy that in the literature there are numerous
papers concerned with the hepatoprotective effect of extracts and
compounds obtained from medicinal plants against the liver
damage induced by several chemical substances, such as carbon
tetrachloride (CCl4), ethanol (EtOH), acetaminophen (or para-
cetamol), among others; but there is a scarcity of research that
describes this effect against the damage generated by the
administration of anti-TB drugs -RIF/INH/PZA- [26].
2. Plants extract with hepatoprotective effect
The ethanol (EtOH) extract from the leaves of Cnidoscolus
chayamansa administered orally demonstrated a protective ef-
fect in Wistar rats against the hepatotoxicity induced by the
mixture of RIF/INH (100 mg/kg each), this extract diminishing
AST, ALT and ALP levels. The observed effect was similar to
that of the positive control (silymarin, 2.5 mg/kg), the authors
attributing this protection to the ﬂavonoids present in the plant
extract [27].
The aqueous extract of Allium sativum bulbs (fresh garlic
homogenate, 0.25 g/kg/d) generates a hepatoprotective effect
against the sub-acute liver damage induced by the mixture of
INH/RIF (50 mg/d, each) administered by oral via, half an hour
before anti-TB drugs over a period of 28 d in Wistar rats. The
results showed that ALT, AST and total bilirubin levels were
reduced in animals receiving the garlic extract and RIF/INH,
with respect to the group where only RIF/INH was administered.
The authors also observed an increase in the glutathione level
and a low level of lipid peroxidation; the effect observed was
attributed to the presence of thiosulﬁnates, steroids, terpenes,
ﬂavonoids and other phenols present in garlic [17]. Allium
sativum (250 mg/kg, oral via), administered by 28 days also
protects from liver injury caused only with INH (50 mg/kg);
the effect observed was similar to that of silymarin (200 mg/
kg) employed as a positive control [28].
Another scientiﬁc paper report the evaluation of four extracts
[petroleum ether, Chloroform (CHCl3), Methanol (MeOH) and
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of hepatotoxicity induced with the mixture of INH (7.5 mg/kg),
RIF (10 mg/kg) and PZA (35 mg/kg) in Wistar rats. The MeOH
extract, followed by the aqueous extract administered orally
exhibited signiﬁcant hepatoprotective activity on attenuating
toxic effects in the liver produced by anti-TB drugs. Biochem-
ical parameters and reduction of hepatocellular necrosis were
very similar to the positive control silymarin (100 mg/kg); the
authors contribute the antioxidant effect of the extract to the
presence of ﬂavonoids [14].
The EtOH (95%) extract from the aerial part of Asteracantha
longifolia (A. longifolia; syn. Hygrophila auriculata) exhibited a
hepatoprotective effect on male Sprague–Dawley rats against the
damage induced with the mixture of INH/RIF (50 mg/kg each),
the EtOH extract was administered at dose of 500 mg/kg/d, by
oral via for 28 d. The authors found that this extract restored
ALT, AST and ALP levels and accelerated the regeneration of
hepatic cells [29]. The hepatoprotective effect has also been
described of the aqueous extract of A. longifolia (complete
plant and root) against the acute damage caused by CCl4 and
acetaminophen [30–32]. The plant's MeOH extract also showed
a hepatoprotective effect against damage caused by
acetaminophen [33]. The alkaloid-rich fraction from the MeOH
extract of A. longifolia demonstrated a hepatoprotective effect
in vitro model [human hepatocellular carcinoma (HepG2)] and
in vivo (in Wistar rats) on inducing injury with CCl4; the pro-
tective effect observed similar to that of silymarin [34].
A similar study was performed on Wistar rats treated with the
EtOH (50%) extract from Ziziphus oenoplia (L.) Mill. roots in a
hepatotoxicity model induced by INH/RIF (50 mg/kg each); the
extract was administered orally for 21 d. The results at doses of
300 mg/kg were very similar to those of the control group
(silymarin, 100 mg/kg) in restoring the serum levels of AST,
ALT, ALP and bilirubin [35].
The hepatoprotective effect is also reported by the acetonic
(70%) extract from the fruit of Punica granatum (P. granatum)
against the hepatotoxicity induced by the mixture of INH/RIF
(50 mg/kg each, administered by intraperitoneal -i.p.- via). The
INH/RIF was co-administrated with 400 mg/kg of the extract for
15 d on male Wistar rats by oral via; the authors found that the
extract diminished OS by reducing lipoperoxidation. P. gran-
atum inactivates FR and increasing the activity of the antioxi-
dant enzymes SOD, CAT, GST and Gluthathione Peroxidase
(GPx), these enzymes constituting the most important endoge-
nous antioxidant defense systems which limit the toxicity
associated with the FR formed during damage induced by anti-
TB drugs [22]. Likewise, the EtOH extract of P. granatum (peel)
and of Vitis vinifera (seeds) administered on male Wistar rats for
12 weeks confers protection from the hepatocellular injury
caused by diethylnitrosamine [36]. The MeOH (95%) extract
from Pisonia aculeata (250 and 500 mg/kg) suspended in
acacia gum at 5% demonstrated a protective effect in Wistar
rats against injury induced with RIF and INH (100 and
50 mg/kg, respectively), normalizing AST, ALT, ALP and
total bilirubin levels, inhibiting cytochrome P450, augmenting
nicotinamide adenine dinucleotide phosphate (NADPH) levels
and diminishing lipid peroxidation, the effect being close to
that generated by the control of silymarin [25].
Cissampelos pareira (EtOH extract) is another medicinal
plant with hepatoprotective activity against damage liver
induced by INH/RIF (50 mg/kg each) on Wistar rat; this extract
was tested at 100 200 and 400 mg/kg by intraperitoneal viaadministered for 28 d. In this case, the author used silymarin
(200 mg/kg) as positive control. The result showed that this
extract reduces the levels of SGPT, SGOT, SALP, total protein,
albumin, total bilirubin; the effect was similar to that showed by
silymarin and was dose-dependent [37]. The EtOH extract of
Cissampelos pareira was also active against CCl4 induced
hepatotoxicity damage [38]. The EtOH extract of Cucumis
trigonus (fruit) was tested as hepatoprotective agents against
liver damage induced by RIF/INH (at 50 mg/kg each) in
Wistar rats. This extract was tested at 100 250 and 500 mg/kg,
administered for 21 d by i.p. route. The group that received
500 mg/kg of extract showed similar levels of SGOT, SGPT,
SALP and GGTP to the silymarin group. Total bilirubin,
conjugated bilirubin, unconjugated bilirubin, total protein,
albumin and globulin levels were better in the extract-treated
group (500 mg/kg); in this group, the histological analyses
revealed a normal liver architecture [39]. Other plants species
such as Mentha peprita, Origanum vulgare and Pimpinella
anisum and mixture of these were tested against damage
induced by INH (150 mg), RIF (300 mg), PZA (500 mg) and
ETB (500 mg) on Sprague–Dawley rats. The anti-TB mixture
was administered 30 min prior to each extract or the plant
mixture and the administration was performed during 30 d. At
the end, the results showed that the hepatoprotective effect
comprised silymarin > polyherbal > Mentha peprita > Orig-
anum vulgare, Pimpinella anisum [40].
On the other hand, among the scarce investigations carried
out on patients, there is a clinical study conducted on patients
diagnosed with TB, who were co-administered for 4 weeks with
a polyherbal mixture [Phyllanthus niruri (P. niruri), Curcuma
xanthorrhiza and Curcuma longa (C. longa)] together with TB
multi-therapy. The authors found that the polyherbal mixture
prevents the rise in ALT with respect to those treated with anti-
TB drugs alone; thus, the authors concluded that this polyherbal
mixture possesses a hepatoprotective effect [41].
The capsule (500 mg) with a polyherbal preparation known
as Livina was tested in a clinical trial in TB patients. Livina
comprise of Picrorhizha kurroa, P. niruri, Andrographis pan-
iculata, Cichorium invitybus, Tephrosia purpurea, Solanum
dulcamara, Crenum aciaticum, Astonia seholanis (50 mg each),
Holarrhave antidysenteric, Tinospora cordifolia (T. cordifolia),
Terminala chebula and A. longifolia (25 mg each). Two cap-
sules of Livina were administered twice daily after meals for six
months. The levels of SGOT, SGPT, ALP were lower in Livina
treated group with respect to the placebo group at weeks 4 and 8
after treatment. The authors suggest that Livina was efﬁcacious
against hepatic dysfunction caused by anti-TB in patients with
TB [42]. Another species that has been evaluated as a
hepatoprotective agent against damage induced with EtOH
40% administered for 21 d or with a mixture of INH (27 mg/
kg), RIF (54 mg/kg) and PZA (135 mg/kg) administered for
21 d in Wistar rats is the MeOH extract from the Cassia
auriculata root. This extract was administered at 300 and
600 mg/kg by oral via during 30 d in both assays. It was
observed that the Cassia auriculata extract reduced AST,
ALT, ALP, total bilirubin and total cholesterol levels and
stimulated the activity of the endogenous enzymatic systems,
such as CAT, GPx and SOD. The authors concluded that the
hepatoprotective effect is due to maintaining the integrity of
the hepatocyte cellular membrane, reducing the concentration
of liver enzymes in serum and increasing the endogenous
antioxidant effect of the organisms. These latter results were
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extract from Moringa oleifera leaves administered orally
during 45 d at 150, 200 and 250 mg/kg also demonstrated a
signiﬁcant protective effect against the damage induced by
INH, RIF and PZA (at doses of 7.5, 10, and 35 mg/kg,
respectively) on Wistar rats; in this study, the authors
employed silymarin as a positive control (200 mg/kg). The
authors found that AST, ALT and ALP, total bilirubin,
cholesterol and triglycerides levels were similar in the extract
group treated with 250 mg/kg and in the silymarin group, also
increase the level of antioxidants enzyme and showing a
reduction of lipid peroxidation in this group [44,45].
Furthermore, the MeOH extract of Annona squamosa leaves
showed a hepatoprotective effect on RIF/INH –induced liver
damage (100 mg/kg each) in Wistar rats; treatment was
administered during 21 d orally. In this study, the authors
employed silymarin as positive control. The extract of Annona
squamosa at 250 and 500 mg/kg, reduced ALT, AST, ALP,
gamma-glutamyl transpeptidase (GGT), protein and total bili-
rubin levels. The GSH levels increased in group treated with
extract and silymarin. This hepatoprotective effect showed by
the extract was similar to that exhibited by silymarin [46]. The
result of a study conducted in Dunkin-Hartley guinea pigs
with liver damage caused by INH (50 mg/kg), RIF (100 mg/kg)
and PZA (300 mg/kg) and treated for 21 d with 200 mg/kg of
each extract of C. longa, Ocimum sanctum, T. cordifolia and
Ziziphus mauritiana; revealed that these plants possess a good
hepatoprotective effect. In the extract treated group showed
normal architecture in the liver histology, no steatosis, no
inﬂammation, and no triaditis or necrosis was observed. The
most active plants among these were C. longa and T. cordifolia
[11]. These latter two species (C. longa and T. cordifolia) were
evaluated in patients with TB; the results indicated that
patients treated with anti-TB drugs and these medicinal spe-
cies showed a reduction in the incidence of hepatotoxicity (2/
316 patients) as compared with the group treated with anti-TB
drugs alone (27/192 patients). The proportion of hepatitis also
diminished, as well as AST, ALT and bilirubin levels in patients
treated with medicinal plants; thus, the authors concluded that
this mixture of plants exerts a hepatoprotective effect in vivo.
Similarly, Ocimum sanctum is a hepatoprotector against the liver
damage caused by acetaminophen on rats [47]; while T.
cordifolia and Ziziphus vulgaris are hepatoprotectors against
the damage caused by CCl4 [48,49]. Oral administration during
one month of 1 mL/kg of the decoction extract from Artemisia
vulgaris (A. vulgaris) (prepared with 1 g leaves/mL water)
was given on male and female Wistar rats with hepatotoxicity
damage induced by antitubercular drugs (RIF, 54 mg/kg/d;
INH, 27 mg/kg, d; PZA, 135 mg/kg/d). A. vulgaris leaves
were collected at different seasonal time. The result showed
that A. vulgaris collected in the May–June period exerts a
better hepatoprotective effect in this model [50].
The hepatoprotective effect of the aqueous extract from
Tamarindus indica fruit (250 and 500 mg/kg) was evaluated
against liver damage induced with INH (50 mg/kg) and RIF
(100 mg/kg) in Wistar rats; this extract decreased the liver
enzyme (AST, ALT and ALP) level as well as bilirubin and
TBARS in serum. Additionally, the extract at 500 mg/kg
increased the activity of the antioxidant systems (GSH, SOD and
CAT) with simultaneously lowered values of lipid peroxidation.
The effect observed was better at 500 mg/kg than at lower dosis
(250 mg/kg); ﬁnally, the microscopic structure of hepatocyteswas similar to that shown by silymarin after 14 d of adminis-
tration [51]. In addition, tablets with decoction of Tamarindus
indica leaves showed a hepatoprotective effect against CCl4
liver damage [52]. The Cuscuta reﬂexa (aerial parts) MeOH
extract is another medicinal plant with signiﬁcative
hepatoprotective effect against hepatotoxicity induced by RIF
(100 mg/kg) and INH (100 mg/kg). This extract was
administered in Albino rats at 100, 200 and 400 mg/kg by i.p.
via, and silymarin was employed as positive control. In this
assay, the MeOH extract showed that ALT, ASP, ALP, g-GT,
total bilirubin and total proteins levels were similar to those of
the silymarin group; these results were conﬁrmed with
histological analyses [53].
The EtOH extract from whole Solanum xanthocarpum was
also tested on Wistar rats. This extract was administered at doses
of 125 and 250 mg/kg during 28 d and liver damage was
induced with INH/RIF (50 mg/kg of each); silymarin at 100 mg/
kg was utilized as positive control. The EtOH extract showed a
hepatoprotective effect through regulation to normal values of
liver enzyme (ALP, AST and ALT) levels in serum; in addition,
it increased antioxidant activity in liver (SOD, CAT and GSH).
The authors associated this beneﬁcial effect with the content of
secondary metabolites such as alkaloids and ﬂavonoids, which
decrease the oxidative damage on liver cells [54]. On the other
hand, the EtOH extract from Solanum xanthocarpum (fresh
and matured fruits) at 100 200 and 400 mg/kg was
administered by i.g. via in the Wistar rats during 35 d.
Hepatotoxicity damage was induced with INH/RIF/PZA (7.5,
10 and 35 mg/kg each) and silymarin was used as positive
control (100 mg/kg). This extract reduce the lipid peroxidation
(LPO) levels, restored the endogenous antioxidant system
(GSH, SOD and CAT), reduced hepatocellular necrosis and
inﬂammatory cell inﬁltration; this effect was dose dependent
[55]. Kalpu et al. evaluated, in the same hepatotoxicity model,
the protective activity of aqueous extract of a polyherbal
Indian formulation known as Vasaguduchyadi Kwatha (a
mixture of eight medicinal plants) on liver injury induced by
the administration of anti-TB drugs (INH 27 mg/kg, RIF
54 mg/kg and PZD 135 mg/kg) in Wistar rats during 60 d. The
results showed that at a 5.04 mL/kg dose, the polyherbal remedy
decreased liver enzyme (ALT and AST) and bilirubin levels in
serum, as well as attenuated hepatocellular necrosis and led to a
reduction of inﬂammatory cell inﬁltration [56].
Another polyherbal Indian formula known as Hepatoplus™
[the capsule contains: Phyllanthus amarus (whole plant)
100 mg, Eclipta alba (leaves) 50 mg, Tephrosia purpurea
(leaves) 30 mg, C. longa (rhizome) 30 mg, Picrorhiza kurroa
(root) 20 mg, Withania somnifera (root) 100 mg, Pinius succi-
nifera (amber) 37.50 mg, Pistacia lentiscus (resinous exudates)
25 mg, Orchis mascula (seed) 25 mg and Cycas circinalis
(ﬂower) 62.50 mg] was evaluated against anti-TB-induced liver
toxicity (INH/RIF 50 mg/kg each) in Sprague Dawley rats at a
dose of 50 and 100 mg/kg for 30 d. LIV 52 (each tablet contains
Capparis spinosa 32 mg, Cichorium intybus 32 mg, Mandur
bhasma 32 mg, Solanum nigrum 32 mg, Terminalia arjuna
32 mg, Cassia occidentalis 16 mg, Achillea millefolium 16 mg
and Tamarix gallica 16 mg) was used as positive control at
100 mg/kg. Hepatoplus™ exhibited a good protection against
oxidative damage by increasing antioxidant defenses (GPx,
CAT, SOD and GSH), and also restored serum levels of liver
enzymes; although the hepatoprotective effect was dose depen-
dent, the effect observed was similar to the control LIV52 [57].
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30 d in Sprague Dawley male was effective against oxidative
damage generated by anti-TB-induced hepatotoxicity,
decreasing LPO levels and DNA damage by one half in the liver
cells. Additionally, the gene expression of caspases and oxidases
such as CYP2E1 was regulated by the co-administration of
Hepatoplus; the activity and levels of antioxidant defenses such
as GPx, CAT, SOD and GSH were increased in the hepatocytes
of rats treated with the polyherbal remedy. In this case, the au-
thors used LIV 52 (100 mg/kg) as positive control [58].
Another study, rats treated with Hepatoplus™ revealed
normal architecture of liver cells and demonstrated the in vitro
hepatoprotective effect of the same polyherbal formulation on
liver cell lines against oxidative-induced damage through a
mixture of INH/RIF (30 ng/mL). The cell line was treated with
three concentrations of Hepatoplus™ (50, 100 and 200 ng/mL).
Liver cell lines treated with Hepatoplus™ were protected from
oxidative stress and maintained a normal antioxidant proﬁle and
liver marker enzymes in a dose-dependent manner. The authors
concluded that Hepatoplus™ protects hepatocytes from OS and
apoptosis [59].
The EtOH extract from the aerial parts of Acanthospermum
hispidum (400 mg/kg) was evaluated for 28 d against liver injury
induced by anti-TB drugs (RIF 40 mg/kg, INH 27 mg/kg, PZA
66 mg/kg and EMB 53 mg/kg) on Wistar rats. This plant extract
reduced the level of liver enzymes in serum and microscopic
analysis revealed that liver tissue was regenerated [60]. The same
beneﬁcial effect was observed when mice with INH-induced
liver injury (100 mg/kg) were treated with Saccharum ofﬁcina-
rum juice (15 mL/kg) during 30 d, provoking a decrease in
serum bilirubin, ALT, AST and ALP levels [61].
In a recent study carried out by Wali et al. in 2015, the hep-
atoprotective activity of the propolis EtOH extract from Kashmir
Himalaya (200 and 400 mg/kg) was evaluated against oxidative
liver damaged induced by the INH/RIFmixture (100 mg/kg, each)
on rats for 14 d. The result showed that propolis at both doses
regenerated the liver tissue and modulated oxidative liver injury
markers; it also demonstrated a decrease of liver damage caused by
INH/RIF. The authors correlated this hepatoprotective effect
shown by propolis with its metabolites, such as ﬂavonoids and
phenolic acids, through their antioxidant potential, demonstrating
this capacity by DPPH inhibition in vitro [62].
The aqueous extract from Azadirachta indica was adminis-
tered with anti-TB drugs (INH/RIF/PAZ 27/54/135 mg/kg/d)
during 30 d on Wistar rats by oral via. The author found that this
extract prevented the biochemical changes in serum; the levels
of bilirubin, protein, ALT, AST and ALP were similar to those
of the silymarin control group [63]. On the other hand, the MeOH
extract from Ficus religiosa leaves was tested against liver
damage induced with INH/RIF (100 mg/kg, each) in Wistar
albino rats; the extract was tested at 100, 200 and 300 mg/kg
and was administered during 21 d by oral via. LIV 52 was use
positive control. The result revealed that the MeOH extract
reduced SGPT and SGOT levels at similar values to those of
the LIV 52 group but total protein, albumin ad ALP levels
were similar to the INH/RIF group. Histological analysis of
the liver showed protection, because the animal group treated
with MeOH extract shown a normal hepatic architecture [64].
This extract showed a hepatroprotector effect against liver
damage induced with paracetamol [64].
Many other plant species such as Ferula asafoetida,
Momordica charantia, Nardostachys jatamansi, Launeaeprocumbens, Terminalia catappa [65], Ficus palmata, Vitis
vinifera [66–69]; Andrographis paniculada, Phyllacanthus
emblica, P. niruri, Thymus vulgaris [70]; Citrus paradisi,
Vaccinium spp., Cactus pear, Opuntia ﬁcus-indica, Matricaria
chamomilla, Camomilla recutita, Hibiscus esculentus [71];
Juniperus phoenocea [72]; C. longa [73,74]; essential oil and
MeOH extract from Rosmarinus ofﬁcinalis [75–78] and others
plants extract, have been evaluated as hepatoprotective agents
against damage induced by CCl4, EtOH, D-galactosamine, and/
or acetaminophen. However, their protector effect is unknown
against damage caused by anti-TB drugs [79,80].
3. Pure natural compounds with hepatoprotective
effect
Scarce studies have been carried out that are focused on
evaluating the protective effect of some of the compounds ob-
tained from medicinal plants with regard to damage caused by
anti-TB drugs. To our knowledge, only silymarin, curcumin,
naringenin, resveratrol and N-trans-caffeoyldopamine have been
evaluated. It is noteworthy that the hepatoprotective effect of
certain natural compounds against damage caused by EtOH,
CCl4, paracetamol and/or acetaminophen has been described.
Antioxidant activity comprises the principal mechanism of ac-
tion of several substances possessing a hepatoprotective effect
[27].
Silymarin is a standardized mixture with high antioxidant
power, a mechanism by which it is thought to exert its hep-
atoprotective effect on damage produced by FR generated by
anti-TB drugs, EtOH, acetaminophen, CCl4 and others. Sily-
marin is obtained from Silybum marianum and is frequently used
for the treatment of liver diseases worldwide; it is endowed with
antioxidant, anti-inﬂammatory, immunomodulatory, anti-
proliferative, antiviral, and antiﬁbrotic activity [21]. It contains at
least seven ﬂavolignans, the most important of which comprise
silybin A, silybin B, silydianin, silycristin and isosilybin A and
B, among others. Silybin A is the most important compound and
represents 50%–70% of the extract of silymarin, being absorbed
20%–50%.
A study was carried out on Wistar rats with liver damage
caused by the administration of RIF/INH (100 and 50 mg/kg,
respectively) and with the mixture of RIF/INH/PZA (100, 50
and 350 mg/kg, respectively), co-administered for 14 d with
silymarin (200 mg/kg). The results showed that silymarin pro-
tects the liver damage caused by the mixture of anti-TB drugs
and it regenerates in liver, the biochemical changes induced by
the mixture of RIF/INH or RIF/INH/PZA. This effect is due to
that silymarin reduced ALT and AST levels to normal values
and also reduced serum albumin, total protein and bilirubin
values. In addition, the liver of the animals under study that
received anti-TB drugs and silymarin did not induce steatosis,
necrosis, or ﬁbrosis. The authors suggest that silymarin can be
employed as a nutritional supplement in patients treated with
anti-TB drugs [21]. Furthermore, it has been demonstrated that
silymarin (150 mg/kg) administered orally possesses a
hepatoprotective effect similar to that of N-acetyl-cysteine in
the case of acute injury caused by acetaminophen [81]. It is
noteworthy that silymarin is frequently employed as a positive
control in the search for substances with a hepatoprotective
effect. Silymarin has also exhibited a beneﬁcial effect on anti-
TB-induced hepatotoxicity in rabbits (INH 50 mg/kg). At a
50 mg/kg dose administered during 6 months, bilirubin and ALT
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The in vivo hepatoprotective effect of silymarin has been
reported in a double-blind study of patients with TB and its
treatment (INH, 5 mg/kg/d; RIF, 10 mg/kg/d; PZA, 25 mg/kg/
d and EMB, 15 mg/kg per day). The treated group received
silymarin (140 mg tablet, 3 times a daily) during 2 months, while
the placebo group received tablets similar in appearance to those
of silymarin. The author found that silymarin protects the liver
damage caused by anti-TB drugs without demonstrating an
adverse effect. It was observed that serum ALP, GGT, ALT and
AST values were higher than those shown by the placebo group.
Also, it was described that SOD restoration can comprise a
mechanism which explains the beneﬁcial effect exhibited by
silymarin [10].
Another natural compound that showing a hepatoprotective
effect in vivo is the ﬂavonoid naringenin; in the case of damage
caused by CCl4 in mice, the authors observed that naringenin
restores ALT and AST levels and improves the activity of SOD
and GPx, avoiding lipid peroxidation and, in turn, avoiding
hepatocyte necrosis, steatosis, and ﬁbrosis [83,84]. This ﬂavone
also provides protection from the liver damage caused by
dimethylnitrosamine in rats, against the damage generated by
acetaminophen in mice and against the chronic damage (60 d)
caused by EtOH. The authors report that naringenin restores
ALT, AST, ALP, bilirubin, albumin and total proteins serum
levels and, reducing the lipid oxidation in the liver [85,86]. It is
noteworthy that naringenin possesses signiﬁcant antioxidant
and hepatoprotective activity; however, to date, its
hepatoprotector effect against anti-TB drugs induced damage
was not been described.
In a study in vitro with the HepG2 cell line, the authors tested
the hepatoprotective effect of the mixture of silymarin, curcumin
and N-acetylcysteine against the liver damage caused with the
INH/RIF/PZA mixture. The results revealed that the mixture of
these natural compounds increases cell viability, maintains cell
morphology and does not alter mitochondrial activity [18]. The
protective effect in vivo against liver damage caused by anti-
TB drugs is not described.
Curcumin is another natural compound in which the in vivo
hepatoprotective effect has been demonstrated (Wistar rats)
against liver damage caused by acetaminophen; the authors
report that it diminishes the expression of MetalloProteinase 8
(MMP-8) and increases the expression of genes encoding anti-
oxidant enzymes in the liver [87]. This compound also
demonstrated a hepatoprotective effect against acute and
subacute liver damage caused by CCl4 [88,89], paraquat [90],
EtOH in vitro and in vivo [91,92] and dimethylnitrosamine [93];
however, the hepatoprotective effect against damage induced
by anti-TB drugs has not been described.
The mixture of Picroliv, curcumin and ellagic acid demon-
strated a protective effect against the acute liver damage caused
by CCl4 and paracetamol in mice and rats [88,94]. However,
elucidation is still lacking on its protective effect against the
liver damage caused by anti-TB multi-therapy.
Resveratrol is another natural compound that has been
evaluated against the acute liver damage caused by the mixture
of INH (50 mg/kg) and RIF (100 mg/kg) in male Balb/C mice.
This compound, at a dose of 100 mg/kg, was administered
30 min prior to the RIF/INH mixture during 3 d. The results
showed that resveratrol reduced AST and ALT serum levels by
36% and 58%, respectively, with regard to animals treated only
with anti-TB drugs alone; the authors also observed thatglutathione and CAT levels were higher in the Resveratrol/RIF/
INH-treated group with respect to the RIF/INH group; likewise,
the group that received resveratrol-RIF/INH exhibited lower
myeloperoxidase values (19%) than the RIF/INH group.
Through histological analysis, the authors observed less micro-
vesicular steatosis and apoptosis in the livers of animals that
received resveratrol-RIF/INH with respect to the group that was
administered anti-TB drugs. The authors recommend the use of
this substance to revert the damage caused by anti-TB drugs.
This compound also protects against liver damage caused by
acetaminophen and EtOH [95].
N-trans-Caffeoyldopamine isolated from Capsicum annuum,
Theobroma cacao and Lycium chinense was tested at 2.5 mg/kg
against oxidative damage induced by anti-TB drugs (INH/RIF
100 mg/kg each) on male Wistar rats. This natural compound
showed a protective effect due to its good antioxidant activity,
increasing SOD and GSH levels in hepatic tissue and signiﬁ-
cantly decreasing liver-enzyme levels (AST, ALT and ALP), as
well as the lipid peroxidation in liver. It is therefore, suggested
that N-trans-Caffeoyldopamine can provide a deﬁnite protective
effect against acute hepatic injury caused by INH/RIF in rats,
which may mainly be associated with its antioxidative effect.
This compound inhibited LPO through the CYP4502E1 down-
regulation [96].
On the other hand, the triterpenes Oleanolic Acid (OA, 3-b-
hydroxy-olea-12-en-28-oic acid) and Ursolic Acid (UA, 3-b-
hydroxyurs-12-en-28-oic acid) possess an important hep-
atoprotective effect against the liver damage caused by EtOH,
CCl4, D-galactosamine, acetaminophen, cadmium, bromo-
benzene, phalloidin, thioacetamide and other hepatotoxic sub-
stances [97–100]. In China, clinical-phase experiments have been
conducted on patients with acute and chronic hepatitis, who
were treated with OA administered by oral via during 3 months
or more. The authors found that the compound demonstrated a
beneﬁcial effect with respect to the placebo group; this com-
pound diminished AST and ALP serum levels, as well as
cirrhosis in cases of chronic hepatitis. Recently, was published
the results on the hepatoprotective effect of the mixture of ole-
anolic and ursolic acid (OA/UA, obtained from Bouvardia ter-
nifolia) against liver injury induced with INH (10 mg/kg), RIF
(10 mg/kg) and PZ (30 mg/kg) in BALC/c mice. The animals
received by subcutaneous via this OA/UA mixture at 100 and
200 mg/mouse daily during 11 weeks. The results showed that
this mixture generates an increase on body weight gain
compared to the anti-TB-drugs group, also reduced the level of
ALT and AST. In addition, histological analysis of livers from
anti-TB group showed a steatosis and increased apoptosis, these
effects was no detected in anti-TB plus OA/UA group [101].
Some naturally-occurring compounds such as saikosaponin,
isolated from C. longa, quercetin, anthocyanin, esculin, retinol,
a-Tocopherol and lycopene have been evaluated as hep-
atoprotective agents against damage caused by CCl4, EtOH and
acetaminophen [1,16]. However, to date, the beneﬁcial effect of
these substances against injury caused by anti-TB drugs re-
mains unknown.
4. Conclusions
The combination of RIF, INH and PZA is considered a basic
drug for treating TB, but these induce hepatotoxicity favoring
treatment suspension and the appearance of MDR cases. On the
other hand, TB and HIV co-exist in the same population,
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medicinal plants and compounds obtained from them comprises
a necessary alternative to consider in the search of hep-
atoprotective agents for managing liver damage produced by
anti-TB drugs. In this regard, we can mention that, to date, there
are few plant species that have been evaluated in vivo against the
liver damage induced by anti-TB drugs and that only six natural
compounds (silymarin, curcumin, N-trans-caffeoyldopamine,
OA/UA mixture and resveratrol) have been described as hep-
atoprotective compounds. Currently, only three articles, to our
knowledge, have described the hepatoprotective effect of poly-
herbal preparation in patients with TB, and evaluation of the
hepatoprotective effect of pure compounds has not been per-
formed. The results found show that these medicinal species and
compounds do indeed exert a hepatoprotective effect and that
they can be candidates for use in minimizing the liver damage
caused by anti-TB drugs.
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